Buy Leap Therapeutics Stock | LPTX Stock Price & Latest News | Public.com
LPTX

Leap Therapeutics

$0.00 (0.00%)Today
    Small Market Cap
    View Leap Therapeutics (LPTX) stock trends here

    About LPTX

    Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01, which is a monoclonal antibody that inhibits Dickkopf-related protein 1, or...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.04
    -0.08
    -0.12
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.10

    Actual EPS
    Q1 2021

    Stats

    Market Cap$128,26M
    Volume527,83k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$3.24
    1 Year Low$1.15
    Open$2.05
    High$2.16
    Low$1.90

    Buy any stock with any amount of money.

    Download the App
    Download the app